FRANCES HODAPP: Open Payments
NPI 1821706748 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 61 payments from 19 companies in 2025. Trend: 2023 $1,440 · 2024 $1,789 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $262 |
| GlaxoSmithKline, LLC. | 5 | $205 |
| ABBVIE INC. | 7 | $205 |
| Novo Nordisk Inc | 11 | $177 |
| Lilly USA, LLC | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $80 |
| Astellas Pharma US Inc | 4 | $60 |
| SHIELD THERAPEUTICS INC | 1 | $57 |
| SANOFI-AVENTIS U.S. LLC | 3 | $52 |
| Exact Sciences Corporation | 3 | $47 |
Products named: VRAYLAR, AIRSUPRA, AREXVY, JARDIANCE, BREZTRI, TRELEGY ELLIPTA, Wegovy, Veozah.
Industry payments across TX — which companies pay providers there.
